NUCYNTA® can be abused in the method much like other opioid agonists, authorized or illicit. This should be considered when prescribing or dispensing NUCYNTA® in situations where by the medical doctor or pharmacist is concerned about a heightened possibility of misuse and abuse. Initial marketed in Europe in 2011, tapentadol https://harlank395dwo2.wikilowdown.com/user